The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 1 , Pages 174-180 , January 2010

Prevention of ischemia/reperfusion-induced pulmonary dysfunction after cardiopulmonary bypass with terminal leukocyte-depleted lung reperfusion

Received 16 April 2009 ,Revised 14 July 2009 ,Accepted 9 August 2009.

References 

  1. Kirklin JK, Blackstone EH, Kirklin JW, McKay R, Pacifico AD, Bargeron LJ. Intracardiac surgery in infants under age 3 months: Incremental risk factors for hospital mortality. Am J Cardiol. 1981;48:500–506
  2. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;86:845–847
  3. Cavarocchi NC, England MD, Schaff HV, Russo P, Orszulak TA, Schnell WA, et al. Oxygen free radical generation during cardiopulmonary bypass: correlation with complement activation. Circulation. 1986;74(Suppl III):III-130-3
  4. Greeley WJ, Bushman GA, Kong DL, Oldham HN, Peterson MB. Effects of cardiopulmonary bypass on eicosanoid metabolism during pediatric cardiovascular surgery. J Thorac Cardiovasc Surg. 1988;95:842–849
  5. Bando K, Pillai R, Cameron DE, Brawn JD, Winkelstein JA, Hutchins GM, et al. Leukocyte depletion ameliorates free radical- mediated lung injury after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1990;99:873–877
  6. Hashimoto K, Miyamoto H, Suzuki K, Horikoshi S, Matsui M, Arai T, et al. Evidence of organ damage following a cardiopulmonary bypass. The role of elastase and vasoactive mediators. J Thorac Cardiovasc Surg. 1992;104:666–673
  7. Ng CSH, Wan S, Arifi AA, Yim APC. Inflammatory response to pulmonary ischemia-reperfusion injury. Surg Today. 2006;36:205–214
  8. Chai PJ, Williamson JA, Lodge AJ, Daggett CW, Scarborough JE, Meliones JN, et al. Effects of ischemia on pulmonary dysfunction after cardiopulmonary bypass. Ann Thorac Surg. 1999;67:731–735
  9. Friedman M, Sellke FW, Wang SY, Weintraub RM, Johnson RG. Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Circulation. 1994;90:262–268
  10. Spies B. Transfusion of blood products affects outcome in cardiac surgery. Semin Cardiothorac Vasc Anesth. 2004;8:267–281
  11. Schnickel GT, Ross DJ, Beygui R, Shefizadeh A, Laks H, Saggar R, et al. Modified reperfusion in clinical lung transplantation: the results of 100 consecutive cases. J Thorac Cardiovasc Surg. 2006;1:218–223
  12. Okabayashi K, Aoe M, DeMeester SR, Cooper JD, Patterson A. Pentoxifylline reduces lung allograft reperfusion injury. Ann Thorac Surg. 1994;58:50–56
  13. Messent M, Sullivan K, Keogh BF, Morgan CJ, Evans TW. Adult respiratory distress syndrome following cardiopulmonary bypass: incidence and prediction. Anaesthesia. 1992;47:267–268
  14. Cox CM, Ascione R, Cohen AM, Davies IM, Ryder IG, Angelini GD. Effect of cardiopulmonary bypass on pulmonary gas exchange: a prospective randomized study. Ann Thorac Surg. 2000;69:140–145
  15. Kaul TK, Fields BL, Riggins LS, Wyatt DA, Jonas CR, Nagle D. Adult respiratory distress syndrome following cardiopulmonary bypass: incidence, prophylaxis and management. J Cardiovasc Surg. 1998;39:777–781
  16. Hashimoto K, Nomura K, Nakano M, Sasaki T, Kurosawa H. Pharmacological intervention for organ protection during cardiopulmonary bypass. Heart Vessels. 1993;8:203–210
  17. Tonz M, Mihaljevic T, von Segesser LK, Fehr J, Schmidt ER, Turina MI. Acute lung injury during cardiopulmonary bypass. Are the neutrophils responsible?. Chest. 1995;108:1551–1556
  18. Halldorsson A, Kronon M, Allen BS, Bolling KS, Wang T, Rahman S, et al. Controlled reperfusion after lung ischemia: implications for improved function after lung transplantation. J Thorac Cardiovasc Surg. 1998;115:415–425
  19. Asimakopoulos G, Smith PL, Ratnatunga CP, Taylor KM. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg. 1999;68:1107–1115
  20. Chen YF, Tsai WC, Lin CC, et al. Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass. Ann Thorac Surg. 2004;78:634–643
  21. Tanita T, Song C, Kubo H, et al. Superoxide anion mediates pulmonary vascular permeability caused by neutrophils in cardiopulmonary bypass. Surg Today. 1999;29:755–761
  22. Ihnken K, Winkler A, Schlensak C, et al. Normoxic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide during cardiac operations in the adult. J Thorac Cardiovasc Surg. 1998;116:327–334
  23. Mashburn JP, Kontos GJ, Hashimoto K, Wilson DM, Schaff HV. The role of neural and vasoactive mediators in the regulation of the pulmonary circulation during cardiopulmonary preservation. J Thoracic Cardiovasc Surg. 1989;98:434–443
  24. Latson TW, Kirckler TS, Baumgartner WA. Pulmonary hypertension and noncardiogenic pulmonary edema following cardiopulmonary bypass associated with an antigranulocyte antibody. Anesthesiology. 1986;64:106–111
  25. Marczin N, Ryan US, Catravas JD. Effects of oxidant stress on endothelium-derived relaxing factor-induced and nitrovasodilator-induced cGMP accumulation in vascular cells in culture. Circ Res. 1992;70:326–340

PII: S0022-5223(09)01089-7

doi: 10.1016/j.jtcvs.2009.08.036

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 1 , Pages 174-180 , January 2010

Article Tools

* Image Usage & Resolution